Tech Company Financing Transactions

Proclara Biosciences Funding Round

On 3/1/2011, Proclara Biosciences received $12.4 million in Series B investment from bioMerieux and private investors.

Transaction Overview

Announced On
3/1/2011
Transaction Type
Venture Equity
Amount
$12,400,000
Round
Series B
Investors

bioMerieux (Lead Investor) (Valerie Calenda)

Proceeds Purpose
The financing will be mostly directed to the IND-enabling activities in preparation of a Phase 1 clinical trial for NPT001, NeuroPhage's lead product candidate for the treatment of Alzheimer's disease, and include further work to expand the platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
125 Cambridgepark Dr. 301
Cambridge, MA 02140
USA
Email Address
Not Recorded
Overview
Proclara Biosciences is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously targeting multiple toxic misfolded proteins.
Profile
Proclara Biosciences LinkedIn Company Profile
Social Media
Proclara Biosciences Company Twitter Account
Company News
Proclara Biosciences News
Facebook
Proclara Biosciences on Facebook
YouTube
Proclara Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Suzanne Bruhn
  Suzanne Bruhn LinkedIn Profile  Suzanne Bruhn Twitter Account  Suzanne Bruhn News  Suzanne Bruhn on Facebook
Chief Medical Officer
David Michelson
  David Michelson LinkedIn Profile  David Michelson Twitter Account  David Michelson News  David Michelson on Facebook
Chief Scientific Officer
Richard Fisher
  Richard Fisher LinkedIn Profile  Richard Fisher Twitter Account  Richard Fisher News  Richard Fisher on Facebook
VP - Manufacturing
Jason Wright
  Jason Wright LinkedIn Profile  Jason Wright Twitter Account  Jason Wright News  Jason Wright on Facebook
VP - Operations
Kelly Magnuson
  Kelly Magnuson LinkedIn Profile  Kelly Magnuson Twitter Account  Kelly Magnuson News  Kelly Magnuson on Facebook
VP - R & D
Rajaraman Krishnan
  Rajaraman Krishnan LinkedIn Profile  Rajaraman Krishnan Twitter Account  Rajaraman Krishnan News  Rajaraman Krishnan on Facebook
VP - R & D
Jonathan Levenson
  Jonathan Levenson LinkedIn Profile  Jonathan Levenson Twitter Account  Jonathan Levenson News  Jonathan Levenson on Facebook
VP - Regulatory Affairs
Roxanne Bales
  Roxanne Bales LinkedIn Profile  Roxanne Bales Twitter Account  Roxanne Bales News  Roxanne Bales on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/1/2011: Lumier venture capital transaction
Next: 3/1/2011: Social Media Networks venture capital transaction

 

Share this article

 


News on VC Transactions

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary